Insider Transactions in Q2 2025 at Bristol Myers Squibb CO (BMY)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 13
2025
|
Christopher S. Boerner Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
62,719
+33.33%
|
-
|
|
Jun 13
2025
|
Christopher S. Boerner Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
62,719
-100.0%
|
-
|
|
Jun 03
2025
|
Bartie Wendy Short EVP, Corporate Affairs |
SELL
Payment of exercise price or tax liability
|
Direct |
3,334
-41.47%
|
$160,032
$48.09 P/Share
|
|
Jun 03
2025
|
Bartie Wendy Short EVP, Corporate Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
8,040
+50.0%
|
-
|
|
Jun 03
2025
|
Christopher S. Boerner Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
62,720
+50.0%
|
-
|
|
Jun 03
2025
|
Christopher S. Boerner Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
62,720
-50.0%
|
-
|
|
May 09
2025
|
Benjamin Hickey President, RayzeBio Org. |
SELL
Open market or private sale
|
Indirect |
97
-100.0%
|
$3,686
$38.01 P/Share
|
|
Apr 25
2025
|
Samit Hirawat EVP,Chief Med.Offr.,Drug Dev. |
BUY
Open market or private purchase
|
Direct |
4,250
+4.84%
|
$199,750
$47.58 P/Share
|
|
Apr 01
2025
|
Karin Shanahan EVP, Glob. Prod. Dev. & Supply |
SELL
Payment of exercise price or tax liability
|
Direct |
1,692
-10.92%
|
$99,828
$59.55 P/Share
|
|
Apr 01
2025
|
Karin Shanahan EVP, Glob. Prod. Dev. & Supply |
BUY
Exercise of conversion of derivative security
|
Direct |
3,306
+17.59%
|
-
|